the effect of adjuvant cmf ( cyclophosphamide , methotrexate , and 5-fluorouracil ) and tamoxifen ( tm ) on hypothalamic-pituitary-ovarian function was studied in 120 women with stage i-ii operable breast cancer .
C0950521
cmf
C0016360
5-fluorouracil